Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients

Abstract Background The prognosis of pancreatic cancer (PC) has been improved by new chemotherapy regimens (combination of 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin (FOLFIRINOX) or gemcitabine plus nab-paclitaxel (GnP)). Unfortunately, chemotherapy-induced peripheral neuropathy (CIPN)...

Full description

Bibliographic Details
Main Authors: Mitsuru Sugimoto, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Yoshinori Okubo, Jun Nakamura, Mika Takasumi, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Takuto Hikichi, Hiromasa Ohira
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Cancer
Subjects:
chemotherapy-induced peripheral neuropathy
mirogabalin
pregabalin
pancreatic cancer
Online Access:https://doi.org/10.1186/s12885-021-09069-9

Internet

https://doi.org/10.1186/s12885-021-09069-9

Similar Items